# A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

> **NCT04477707** · — · COMPLETED · sponsor: **Bayer** · enrollment: 206 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Finerenone (BAY94-8862)

## Key facts

- **NCT ID:** NCT04477707
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-23
- **Primary completion:** 2021-06-25
- **Final completion:** 2021-06-25
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2022-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04477707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04477707, "A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04477707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*